United States · Venture startup

Who invested in resistanceBio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Y Combinator: W19

Funding summaryUpdated 26 Oct 2026

$13Mraised across 1 round since 2024, from 1 source

Latest round
Venture, $13MJan 2024
Investors
5
See who backed them

The rounds

  1. Jan 2024
    Venture$13M

    Source recordedSEC filing: $13M sold, first sale Jan 2024

Founders and team

From the SEC filings it signed: 3 on the team.

  • Christopher BulowExecutive Officer, Directori
  • Kyle LaphamExecutive Officer, Directori
  • Nicholas GoldnerExecutive Officer, Directori

On the board, as filediOmri Amirav-Drory

Everyone who backed them

Y CombinatorAccelerator1round
Alumni VenturesVC firm1round
Liquid 2 VenturesVC firm1round
Pioneer FundPrivate equity1round
Fifty YearsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about resistanceBio

Who invested in resistanceBio?

resistanceBio's investors include Y Combinator, Alumni Ventures, Liquid 2 Ventures, Pioneer Fund and Fifty Years.

How much has resistanceBio raised?

resistanceBio has raised $13M across 1 round since 2024.

When did resistanceBio last raise?

resistanceBio's most recent round was a Venture of $13M in Jan 2024.

What was resistanceBio's biggest round?

Its most recent round, $13M in Jan 2024, is also its largest on record.

Who backed resistanceBio first?

resistanceBio's first round on record, in Jan 2024, was backed by Y Combinator, Alumni Ventures and Liquid 2 Ventures and 2 others.

What stage is resistanceBio at?

resistanceBio's latest named round is a Venture, in Jan 2024.

Where is resistanceBio based?

resistanceBio is based in the United States.

Companies like resistanceBio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.